why choose us

Clinical Trials Search

Showing 7,570 of 132,656 result(s)
Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging

Status: COMPLETED

Condition: Prostate Cancer

Interventions: Subjects will lie in supine position.
The systematic use of a headset will reduce the acoustic noise inherent to the machine.
We are going t

Date: 2023-10-17

Effect of Shellac Nail Polish Application on Pulse Oximetry Measurements in Healthy Individuals

Status: COMPLETED

Condition: Healthy Individuals

Interventions: The middle finger of the left hand of each participant will be the experimental group and the little finger will be the control group.
After the

Date: 2023-10-17

Smartphone App-assisted Short-term Antibiotic Therapy

Status: COMPLETED

Condition: Infection, Bacterial

Interventions: The intervention includes the use of a smartphone-based medication intake reminder, along with two educational and motivational text messages during t

Date: 2023-10-17

National Survey of Young Adult Nutrition

Status: Completed

Condition: Overweight or Obesity

Interventions: Participants will complete study survey and dietary assessment.

Date: 2023-10-17

The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment

Status: Completed

Condition: Cancer

Interventions: Subjects will respond to Electronic patient-reported outcome (ePRO) every week for 8 weeks.

Date: 2023-10-17

A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

Status: NOT_YET_RECRUITING

Condition: NSCLC

Interventions: Specified dose on specified days

Date: 2023-10-17

Use of a Cloud-connected Remote Blood Pressure Monitoring Program During the Postpartum Period for Hypertensive Women

Status: NOT_YET_RECRUITING

Condition: Hypertensive Disorder

Interventions: The BP cuff is connected in a Health Insurance Portability and Accountability Act-compliant fashion to the patient's medical record, allowing for

Date: 2023-10-17

Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency

Status: Completed

Condition: Inherited Bone Marrow Failure Syndrome

Interventions: Imatinib at 100-400 mg PO QD based on arm assignment;dose level

Date: 2023-10-17

Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children

Status: Completed

Condition: Growth Disorders

Interventions: The treatment of children with subcutaneous recombinant human growth hormone (rhGH) is the current gold standard of care for children with diagnosed G

Date: 2023-10-17

Video Vitals and Biomarkers

Status: Completed

Condition: Adults 18 Years and Older (no Other Exclusion Criteria)

Interventions:

Date: 2023-10-17